A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1517-1525

  Cazanave, Sophie C ^a   Mott, Justin L ^a   Elmi, Nafisa A ^a   Bronk, Steven F ^a   Masuoka, Howard C ^a   Charlton, Michael R ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

BH3 only proteins; Free fatty acid; Hepatic steatosis; microRNA; p53 upregulated mediator of apoptosis

Indexed keywords

LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 296; PALMITIC ACID; PUMA PROTEIN; SATURATED FATTY ACID; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LEVEL; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; LIPOAPOPTOSIS; LIPOTOXICITY; LIVER CELL; LIVER LEVEL; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE;

3' UNTRANSLATED REGIONS; AGED; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; CELL LINE, TUMOR; FATTY LIVER; GENE EXPRESSION; GENES, REPORTER; HEPATOCYTES; HUMANS; LIVER; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PALMITATES; PROTO-ONCOGENE PROTEINS;

EID: 79960685445     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M014654     Document Type: Article

References (32)

1. Browning, J. D., L. S. Szczepaniak, R. Dobbins, P. Nuremberg, J. D. Horton, J. C. Cohen, S. M. Grundy, and H. H. Hobbs. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40: 1387-1395.
2. Adams, L. A., J. F. Lymp, J. St. Sauver, S. O. Sanderson, K. D. Lindor, A. Feldstein, and P. Angulo. 2005. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 129: 113-121. (Pubitemid 41002048)
3. Nehra, V., P. Angulo, A. L. Buchman, and K. D. Lindor. 2001. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig. Dis. Sci. 46: 2347-2352.
4. Feldstein, A. E., A. Canbay, P. Angulo, M. Taniai, L. J. Burgart, K. D. Lindor, and G. J. Gores. 2003. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 125: 437-443.
5. Kahraman, A., M. Schlattjan, P. Kocabayoglu, S. Yildiz-Meziletoglu, M. Schlensak, C. D. Fingas, I. Wedemeyer, G. Marquitan, R. K. Gieseler, H. A. Baba, et al. 2010. Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology. 51: 92-102.
6. Barreyro, F. J., S. Kobayashi, S. F. Bronk, N. W. Werneburg, H. Malhi, and G. J. Gores. 2007. Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J. Biol. Chem. 282: 27141-27154.
7. Cazanave, S. C., J. L. Mott, N. A. Elmi, S. F. Bronk, N. W. Werneburg, Y. Akazawa, A. Kahraman, S. P. Garrison, G. P. Zambetti, M. R. Charlton, et al. 2009. JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J. Biol. Chem. 284: 26591-26602.
8. Cazanave, S. C., N. A. Elmi, Y. Akazawa, S. F. Bronk, J. L. Mott, and G. J. Gores. 2010. CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G236-G243.
9. Jabbour, A. M., J. E. Heraud, C. P. Daunt, T. Kaufmann, J. Sandow, L. A. O'Reilly, B. A. Callus, A. Lopez, A. Strasser, D. L. Vaux, et al. 2009. Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim. Cell Death Differ. 16: 555-563.
10. Kim, H., H. C. Tu, D. Ren, O. Takeuchi, J. R. Jeffers, G. P. Zambetti, J. J. Hsieh, and E. H. Cheng. 2009. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell. 36: 487-499.
11. Yu, J., and L. Zhang. 2008. PUMA, a potent killer with or without p53. Oncogene. 27 ( Suppl. 1 ): S71-S83.
12. Cheung, O., P. Puri, C. Eicken, M. J. Contos, F. Mirshahi, J. W. Maher, J. M. Kellum, H. Min, V. A. Luketic, and A. J. Sanyal. 2008. Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology. 48: 1810-1820.
13. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116: 281-297.
14. Guo, H., N. T. Ingolia, J. S. Weissman, and D. P. Bartel. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466: 835-840.
15. Belfort, R., S. A. Harrison, K. Brown, C. Darland, J. Finch, J. Hardies, B. Balas, A. Gastaldelli, F. Tio, J. Pulcini, et al. 2006. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307. (Pubitemid 44837778)
16. Sanyal, A. J., C. Campbell-Sargent, F. Mirshahi, W. B. Rizzo, M. J. Contos, R. K. Sterling, V. A. Luketic, M. L. Shiffman, and J. N. Clore. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120: 1183-1192.
17. Grimson, A., K. K. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell. 27: 91-105.
18. Wei, Y., D. Wang, C. L. Gentile, and M. J. Pagliassotti. 2009. Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells. Mol. Cell. Biochem. 331: 31-40.
19. Cheng, A. M., M. W. Byrom, J. Shelton, and L. P. Ford. 2005. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33: 1290-1297.
20. Zhang, C. Z., J. X. Zhang, A. L. Zhang, Z. D. Shi, L. Han, Z. F. Jia, W. D. Yang, G. X. Wang, T. Jiang, Y. P. You, et al. 2010. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol. Cancer. 9: 229.
21. Veronese, A., L. Lupini, J. Consiglio, R. Visone, M. Ferracin, F. Fornari, N. Zanesi, H. Alder, G. D'Elia, L. Gramantieri, et al. 2010. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res. 70: 3140-3149.
22. Nakagawa, A., Y. Shi, E. Kage-Nakadai, S. Mitani, and D. Xue. 2010. Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease. Science. 328: 327-334.
23. Ghodgaonkar, M. M., R. G. Shah, F. Kandan-Kulangara, E. B. Affar, H. H. Qi, E. Wiemer, and G. M. Shah. 2009. Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. Cell Death Differ. 16: 858-868.
24. Esau, C., S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey, M. Pear, L. Watts, S. L. Booten, M. Graham, R. McKay, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3: 87-98.
25. Lee, J., and J. K. Kemper. 2010. Controlling SIRT1 expression by microRNAs in health and metabolic disease. Aging. 2: 527-534.
26. Yamakuchi, M., M. Ferlito, and C. J. Lowenstein. 2008. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA. 105: 13421-13426.
27. Estep, M., D. Armistead, N. Hossain, H. Elarainy, Z. Goodman, A. Baranova, V. Chandhoke, and Z. M. Younossi. 2010. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 32: 487-497.
28. Alkhouri, N., A. Gornicka, M. P. Berk, S. Thapaliya, L. J. Dixon, S. Kashyap, P. R. Schauer, and A. E. Feldstein. 2010. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J. Biol. Chem. 285: 3428-3438.
29. Lembertas, A. V., L. Perusse, Y. C. Chagnon, J. S. Fisler, C. H. Warden, D. A. Purcell-Huynh, F. T. Dionne, J. Gagnon, A. Nadeau, A. J. Lusis, et al. 1997. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest. 100: 1240-1247. (Pubitemid 27386310)
30. Erlacher, M., V. Labi, C. Manzl, G. Bock, A. Tzankov, G. Hacker, E. Michalak, A. Strasser, and A. Villunger. 2006. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J. Exp. Med. 203: 2939-2951. (Pubitemid 46026171)
31. Malhi, H., F. J. Barreyro, H. Isomoto, S. F. Bronk, and G. J. Gores. 2007. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut. 56: 1124-1131.
32. Brown, B. D., and L. Naldini. 2009. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Natl. Rev. Genet. 10: 578-585.